title: Pretransplant hepatitis C virus infection: a predictor of proteinuria after renal transplantation.
abstract: BACKGROUND
  Reports have suggested that hepatitis C virus (HCV)-infected kidney recipients may develop de novo glomerular lesions caused by the virus. We studied the relationships between pretransplantation anti-HCV antibodies and the occurrence of proteinuria and the link with short- and long-term patient and graft survival.
  
  
  METHODS
  A total of 322 consecutive renal recipients treated at a single center from 1989 to 1994 whose sera were routinely assayed for anti-HCV antibodies at the time of transplantation were analyzed. The risks of persistent proteinuria (>1 g/day), graft loss, or death were estimated by Kaplan-Meier analysis. The relationship between clinical variables and each outcome was examined by Cox multivariate regression analysis.
  
  
  RESULTS
  Before transplantation, 9.6% of the recipients were anti-HCV antibody positive. Persistent proteinuria developed in 13.6% recipients. The presence of anti-HCV antibodies was strongly associated with proteinuria (relative risk [RR]=5.36, 95% confidence interval [CI]=2.49-11.51). Proteinuria occurred more frequently in second grafts (RR=2.64, 95% CI=1.10-6.29). The number of HLA-A,B mismatches was an independent risk factor (RR=1.55, 95% CI=1.10-2.19). Recipient age (RR=0.80, 95% CI=0.63-1.02) and duration of dialysis (RR=0.86, 95% CI=0.77-0.96) were protective factors. Histology of biopsies from 26/44 recipients with proteinuria showed that de novo glomerular lesions were more frequent in HCV-positive patients, although the difference was not significant. One- and five-year graft survival rates were significantly worse in patients with proteinuria (90.7% and 41.1%) than in patients without it (95.6% and 91.8%) (P<0.00001). Despite the strong association between HCV infection and proteinuria, patient and graft survival rates in anti-HCV-positive and anti-HCV-negative recipients were similar.
  
  
  CONCLUSIONS
  The presence of anti-HCV antibodies before renal transplantation seems to be a major risk factor of proteinuria after transplantation. This may be due to glomerular lesions caused by HCV. However, anti-HCV has no impact on 5-year patient and graft survival.
authors.affiliation: Department of Nephrology, University Hospital of Nancy, France.
authors.forename: D
authors.initials: D
authors.lastname: Hestin
authors.forename: F
authors.initials: F
authors.lastname: Guillemin
authors.forename: N
authors.initials: N
authors.lastname: Castin
authors.forename: A
authors.initials: A
authors.lastname: Le Faou
authors.forename: J
authors.initials: J
authors.lastname: Champigneulles
authors.forename: M
authors.initials: M
authors.lastname: Kessler
mesh_terms: D000328:Adult; D002908:Chronic Disease; D005260:Female; D006085:Graft Survival; D006526:Hepatitis C / Q000150:complications*; D018937:Hepatitis C Antibodies / Q000032:analysis; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011507:Proteinuria / Q000150:complications*; D012044:Regression Analysis; D012307:Risk Factors; D016019:Survival Analysis
chemical_list: D018937:Hepatitis C Antibodies